Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Zimmer

Showing results (171-180 of 203) with videos related to

Pageof 21
Sort By:
Journal for Immunotherapy of Cancer|July 27, 2019
A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1-3 inhibitor, cediranib, in recurrent women's cancers with biomarker analysesAlexandra S Zimmer, Erin Nichols, Ashley Cimino-Mathews, et al.
Neurobiology of Disease|August 6, 2022
Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsyAlessia Salamone, Gaetano Terrone, Rossella Di Sapia, et al.
The Oncologist|June 6, 2023
A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial CarcinomaSarah L P Atkins, Yoshimi Endo Greer, Sarah Jenkins, et al.
Life Sciences|September 12, 2020
Parameters predicting COVID-19-induced myocardial injury and mortalityG D Duerr, A Heine, M Hamiko, et al.
Neuropathology and Applied Neurobiology|December 24, 2019
Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformationsT S Zimmer, G Ciriminna, A Arena, et al.
Epilepsia|December 14, 2021
Increased expression of complement components in tuberous sclerosis complex and focal cortical dysplasia type 2B brain lesionsVictoria-Elisabeth Gruber, Mark J Luinenburg, Katrin Colleselli, et al.
Frontiers in Cellular Neuroscience|December 13, 2023
Loss of maturity and homeostatic functions in Tuberous Sclerosis Complex-derived astrocytesMark J Luinenburg, Mirte Scheper, Frederik N F Sørensen, et al.
Neuropathology and Applied Neurobiology|May 18, 2021
Balloon cells promote immune system activation in focal cortical dysplasia type 2bTill S Zimmer, Diede W M Broekaart, Mark Luinenburg, et al.
Glia|February 1, 2018
miR147b: A novel key regulator of interleukin 1 beta-mediated inflammation in human astrocytesJackelien van Scheppingen, James D Mills, Till S Zimmer, et al.
Brain Pathology (Zurich, Switzerland)|October 11, 2018
Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependenceAndrea Arena, Till S Zimmer, Jackelien van Scheppingen, et al.
Pageof 21

Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
Journal for Immunotherapy of Cancer|July 27, 2019
A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1-3 inhibitor, cediranib, in recurrent women's cancers with biomarker analysesAlexandra S Zimmer, Erin Nichols, Ashley Cimino-Mathews, et al.
Neurobiology of Disease|August 6, 2022
Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsyAlessia Salamone, Gaetano Terrone, Rossella Di Sapia, et al.
The Oncologist|June 6, 2023
A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial CarcinomaSarah L P Atkins, Yoshimi Endo Greer, Sarah Jenkins, et al.
Life Sciences|September 12, 2020
Parameters predicting COVID-19-induced myocardial injury and mortalityG D Duerr, A Heine, M Hamiko, et al.
Neuropathology and Applied Neurobiology|December 24, 2019
Chronic activation of anti-oxidant pathways and iron accumulation in epileptogenic malformationsT S Zimmer, G Ciriminna, A Arena, et al.
Epilepsia|December 14, 2021
Increased expression of complement components in tuberous sclerosis complex and focal cortical dysplasia type 2B brain lesionsVictoria-Elisabeth Gruber, Mark J Luinenburg, Katrin Colleselli, et al.
Frontiers in Cellular Neuroscience|December 13, 2023
Loss of maturity and homeostatic functions in Tuberous Sclerosis Complex-derived astrocytesMark J Luinenburg, Mirte Scheper, Frederik N F Sørensen, et al.
Neuropathology and Applied Neurobiology|May 18, 2021
Balloon cells promote immune system activation in focal cortical dysplasia type 2bTill S Zimmer, Diede W M Broekaart, Mark Luinenburg, et al.
Glia|February 1, 2018
miR147b: A novel key regulator of interleukin 1 beta-mediated inflammation in human astrocytesJackelien van Scheppingen, James D Mills, Till S Zimmer, et al.
Brain Pathology (Zurich, Switzerland)|October 11, 2018
Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependenceAndrea Arena, Till S Zimmer, Jackelien van Scheppingen, et al.
Pageof 21